Skip to content
Stop using now Drug recall · FDA · Published March 18, 2015

Mylan Recalls Carboplatin Injection Due to Particulate Matter

Mylan Institutional LLC recalls specific lots of Carboplatin Injection vials due to the presence of particulate matter. Check lot numbers and expiration dates.

🇺🇸 FDA recall #D-1331-2015DrugMylan Institutional ›
Take action

Contact the company

Recalling firmMylan Institutional LLC4901 Hiawatha Dr · Rockford, IL 61103-1287
✎ GovInfoNow plain-language explainer

What happened, in plain English

Mylan Institutional LLC is recalling a specific quantity of Carboplatin Injection vials because they contain visible particulate matter. This Class I recall involves 4,445 vials distributed nationwide. The record does not specify the exact health consequences or the remedy for this recall. Read more at govinfonow.com/recall/44834-mylan-institutional-llc-recalls-carboplatin-injection-450-mg-45-ml.

Source Summary by GovInfoNow · govinfonow.com/recall/44834-mylan-institutional-llc-recalls-carboplatin-injection-450-mg-45-ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-1331-2015

Cite this page

“Mylan Recalls Carboplatin Injection Due to Particulate Matter.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44834-mylan-institutional-llc-recalls-carboplatin-injection-450-mg-45-ml. Based on FDA recall #D-1331-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1331-2015%22&limit=1).

Why it’s dangerous

The presence of particulate matter in an injectable drug can pose serious health risks if the particles enter the bloodstream, potentially causing blockages or other complications. Because this is a Class I recall, it indicates a situation where use could lead to serious adverse health consequences or death.

Who’s affected

Patients receiving chemotherapy treatment who have been administered or may receive Carboplatin Injection manufactured by Mylan Institutional LLC. Healthcare providers handling these specific vials are also affected.

How to tell if you have this one

Look for CARBOplatin Injection 450 mg/45 mL (10 mg/mL) in a 100 mL Multi-Dose Vial. Check the NDC 67457-493-46, UPC 3 67457 49346 6, and Lot # 7801312 with an expiration date of 06/15.

  • Brand
    Mylan Institutional
  • Product
    CARBOplatin Injection 450 mg/45 mL (10 mg/mL), 45 mL packaged in a 100 mL Multi-Dose Vial, Rx only, Manufactured for
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Inventory

    Verify if you have vials matching NDC 67457-493-46, UPC 3 67457 49346 6, and Lot # 7801312.

  2. Consult Healthcare Provider

    Contact your doctor or pharmacist immediately to determine if you have received this recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Mar 18, 201512. FDA classified it Class I: Aug 14, 201523. Published in FDA’s Enforcement Report: Aug 26, 201534. FDA terminated the recall: May 19, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1331-2015 (March 18, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1331-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA